[HTML][HTML] Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
…, DE Furst, AD Sawitzke, H Shi… - … England Journal of …, 2006 - Mass Medical Soc
Background Glucosamine and chondroitin sulfate are used to treat osteoarthritis. The
multicenter, double-blind, placebo- and celecoxib-controlled Glucosamine/chondroitin Arthritis …
multicenter, double-blind, placebo- and celecoxib-controlled Glucosamine/chondroitin Arthritis …
Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial
Context Idiopathic sudden sensorineural hearing loss has been treated with oral corticosteroids
for more than 30 years. Recently, many patients' symptoms have been managed with …
for more than 30 years. Recently, many patients' symptoms have been managed with …
The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial
AD Sawitzke, H Shi, MF Finco… - … : Official Journal of …, 2008 - Wiley Online Library
Objective Osteoarthritis (OA) of the knee causes significant morbidity and current medical
treatment is limited to symptom relief, while therapies able to slow structural damage remain …
treatment is limited to symptom relief, while therapies able to slow structural damage remain …
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from …
AD Sawitzke, H Shi, MF Finco, DD Dunlop… - Annals of the …, 2010 - ard.bmj.com
Background Knee osteoarthritis (OA) is a major cause of pain and functional limitation in
older adults, yet longer-term studies of medical treatment of OA are limited. Objective To …
older adults, yet longer-term studies of medical treatment of OA are limited. Objective To …
[HTML][HTML] Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes
…, KE Wong, Z Zhang, G Ning, Y Zhang, J Kong, H Shi… - Kidney international, 2010 - Elsevier
We recently showed that losartan and paricalcitol are synergistic in the treatment of diabetic
nephropathy in a model of type 1 diabetes. To test this strategy in a model of type 2 diabetes, …
nephropathy in a model of type 1 diabetes. To test this strategy in a model of type 2 diabetes, …
Carbonic acid enhancement of hydrolysis in aqueous pretreatment of corn stover
GP van Walsum, H Shi - Bioresource technology, 2004 - Elsevier
Carbonic acid and liquid hot water pretreatments were applied to corn stover. Temperatures
ranged from 180 to 220 C; reaction times varied between 2 and 32 min and prereaction …
ranged from 180 to 220 C; reaction times varied between 2 and 32 min and prereaction …
Indirect vs direct voice therapy for children with vocal nodules: a randomized clinical trial
Importance Benign vocal fold nodules affect 12% to 22% of the pediatric population, and 95%
of otolaryngologists recommend voice therapy as treatment. However, no randomized …
of otolaryngologists recommend voice therapy as treatment. However, no randomized …
Investigation of polymer/surfactant interactions and their impact on itraconazole solubility and precipitation kinetics for developing spray-dried amorphous solid …
TM Deshpande, H Shi, J Pietryka… - Molecular …, 2018 - ACS Publications
Methods were developed to systematically screen different polymer–surfactant combinations
for the purpose of enhancing amorphous active pharmaceutical ingredient (API) solubility …
for the purpose of enhancing amorphous active pharmaceutical ingredient (API) solubility …
OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group
…, L Punzi, EM Roos, LC Rovati, H Shi… - The Journal of …, 2011 - jrheum.org
Objective. To define pain and physical function cutpoints that would, coupled with structural
severity, define a surrogate measure of “need for joint replacement surgery,” for use as an …
severity, define a surrogate measure of “need for joint replacement surgery,” for use as an …
Recent advances in the understanding of biological implications and modulation methodologies of monoclonal antibody N‐linked high mannose glycans
HH Shi, CT Goudar - Biotechnology and bioengineering, 2014 - Wiley Online Library
With the prevalence of therapeutic monoclonal antibodies (mAbs) in the biopharmaceutical
industry, the use of mammalian cell culture systems, particularly Chinese hamster ovary (…
industry, the use of mammalian cell culture systems, particularly Chinese hamster ovary (…